On February 7, 2011
How a Single Patent Expiry Could Wipe Out 40% of AstraZeneca’s Profits
The antipsychotic drug Seroquel — which loses its exclusive marketing rights in early 2012 — appears to account for a ridiculously huge fraction of AZ’s pretax profit.
No tags for this post.
0 Comments